To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Requirement for YAP1 sign… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Requirement for YAP1 signaling in myxoid liposarcoma.

Journal article
Authors Marcel Trautmann
Ya-Yun Cheng
Patrizia Jensen
Ninel Azoitei
Ines Brunner
Jennifer Hüllein
Mikolaj Slabicki
Ilka Isfort
Magdalene Cyra
Ruth Berthold
Eva Wardelmann
Sebastian Huss
Bianca Altvater
Claudia Rossig
Susanne Hafner
Thomas Simmet
Anders Ståhlberg
Pierre Åman
Thorsten Zenz
Undine Lange
Thomas Kindler
Claudia Scholl
Wolfgang Hartmann
Stefan Fröhling
Published in EMBO molecular medicine
Volume 11
Issue 5
ISSN 1757-4684
Publication year 2019
Published at Sahlgrenska Cancer Center
Department of Laboratory Medicine
Wallenberg Centre for Molecular and Translational Medicine
Language en
Keywords FUS‐DDIT3, Hippo pathway, YAP1; myxoid liposarcoma, verteporfin
Subject categories Cell and Molecular Biology, Cancer and Oncology


Myxoid liposarcomas (MLS), malignant tumors of adipocyte origin, are driven by the FUS-DDIT3 fusion gene encoding an aberrant transcription factor. The mechanisms whereby FUS-DDIT3 mediates sarcomagenesis are incompletely understood, and strategies to selectively target MLS cells remain elusive. Here we show, using an unbiased functional genomic approach, that FUS-DDIT3-expressing mesenchymal stem cells and MLS cell lines are dependent on YAP1, a transcriptional co-activator and central effector of the Hippo pathway involved in tissue growth and tumorigenesis, and that increased YAP1 activity is a hallmark of human MLS Mechanistically, FUS-DDIT3 promotes YAP1 expression, nuclear localization, and transcriptional activity and physically associates with YAP1 in the nucleus of MLS cells. Pharmacologic inhibition of YAP1 activity impairs the growth of MLS cells in vitro and in vivo These findings identify overactive YAP1 signaling as unifying feature of MLS development that could represent a novel target for therapeutic intervention.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?